Please note: If you are not logged in to Twitter on this device already, the story will not be shared. You may click the "Login" link to login to Twitter.
The Office of Medicaid Fraud and Abuse Control announced today that Kentucky will intervene in a civil lawsuit against Healthpoint.
Kentucky is one of 13 states that moved to join the lawsuit claiming that Healthpoint caused Medicaid to pay $90 million in claims for the drug xenaderm, despite the drug's ineligibility for coverage.
The complaint further alleges that Healthpoint actively marketed xenaderm to nursing homes as a medicaid-eligible drug.
Attorney General Jack Conway said he was pleased that the motion to intervene in the lawsuit was granted.